← Open Payments lookup

MICHELE MCINTOSH: Open Payments

NPI 1578104899 · PRINCESS ANNE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$902 in 32 payments from 13 companies in 2025. Trend: 2023 $302 · 2024 $1,140 · 2025 $902

Food & beverage: $902
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.6$245
Vanda Pharmaceuticals Inc.4$179
Lundbeck LLC5$109
ABBVIE INC.3$74
Janssen Pharmaceuticals, Inc2$50
Alkermes, Inc.2$41
Otsuka America Pharmaceutical, Inc.2$41
Axsome Therapeutics, Inc.2$40
Takeda Pharmaceuticals U.S.A., Inc.2$39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25

Products named: INGREZZA, FANAPT, REXULTI, ABILIFY ASIMTUFII, MAVYRET, INVEGA SUSTENNA, ARISTADA, Auvelity.

Industry payments across MD — which companies pay providers there.